An in vivo function for the transforming Myc protein: Elicitation of the angiogenic phenotype

Cell Growth and Differentiation

Volumn 11, Issue 4, 2000, Pages 201-210

  Ngo, Cam V ^a   Gee, Michael ^a   Akhtar, Nasim ^b   Yu, Duonan ^a   Volpert, Olga ^c   Auerbach, Robert ^b   Thomas Tikhonenko, Andrei ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; MATRIGEL; MYC PROTEIN; THROMBOSPONDIN 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; FIBROBLAST; GENE OVEREXPRESSION; MOUSE; NONHUMAN; ONCOGENE MYC; PHENOTYPE; PRIORITY JOURNAL; RAT; TUMOR VASCULARIZATION;

ANIMALS; CATTLE; CELL LINE; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CORNEA; CULTURE MEDIA, CONDITIONED; ENDOTHELIUM, VASCULAR; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MUTATION; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-MYC; TAMOXIFEN;

ANIMALIA;

EID: 0034036779     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Bouchard, C., Staller, P., and Eilers, M. Control of cell proliferation by Myc. Trends Cell Biol., 8: 202-206, 1998.
2. Zornig, M., and Evan, G. I. Cell cycle: on target with Myc. Curr. Biol., 6: 1553-1556, 1996.
3. Grandori, C., and Eisenman, R. N. Myc target genes. Trends Biochem. Sci., 22: 177-181, 1997.
4. Campisi, J., Gray, H. E., Pardee, A. B., Dean, M., and Sonenshein, G. E. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell, 36: 241-247, 1984.
5. Kelly, K., Cochran, B. H., Stiles, C. D., and Leder, P. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell, 35: 603-610, 1983.
6. Roussel, M. F., Cleveland, J. L., Shurtleff, S. A., and Sherr, C. J. Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature (Lond.), 353: 361-363, 1991.
7. Shibuya, H., Yoneyama, M., Ninomiya-Tsuji, J., Matsumoto, K., and Taniguchi, T. IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell, 70: 57-67, 1992.
8. Eilers, M., Picard, D., Yamamoto, K. R., and Bishop, J. M. Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature (Lond.), 340: 66-68, 1989.
9. Biro, S., Fu, Y. M., Yu, Z. X., and Epstein, S. E. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Proc. Natl. Acad. Sci. USA, 90: 654-658, 1993.
10. 1. Nature (Lond.), 328: 445-450, 1987.
11. Kinzler, K. W., and Vogelstein, B. Life (and death) in a malignant tumour. Nature (Lond.), 379: 19-20, 1996.
12. Fidler, I. J., and Ellis, L. M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79: 185-188, 1994.
13. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
14. Bouck, N., Stellmach, V., and Hsu, S. C. How tumors become angiogenic. Adv. Cancer Res., 69: 135-174, 1996.
15. Good, D. J., Polverini, P. J., Rastinejad, F., Le Beau, M. M., Lemons, R. S., Frazier, W. A., and Bouck, N. P. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA, 87: 6624-6628, 1990.
16. Dameron, K. M., Volpert, O. V., Tainsky, M. A., and Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science (Washington DC), 265: 1582-1584, 1994.
17. Stellmach, V., Volpert, O. V., Crawford, S. E., Lawler, J., Hynes, R. O., and Bouck, N. Tumour suppressor genes and angiogenesis: the role of TP53 in fibroblasts. Eur. J. Cancer, 32A: 2394-2400, 1996.
18. Volpert, O. V., Tolsma, S. S., Pellerin, S., Feige, J. J., Chen, H., Mosher, D. F., and Bouck, N. Inhibition of angiogenesis by thrombospondin-2. Biochem. Biophys. Res. Commun., 217: 326-332, 1995.
19. Kyriakides, T. R., Zhu, Y. H., Smith, L. T., Bain, S. D., Yang, Z., Lin, M. T., Danielson, K. G., Iozzo, R. V., LaMarca, M., McKinney, C. E., Ginns, E. I., and Bornstein, P. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J. Cell Sol., 140: 419-430, 1998.
20. Kerbel, R. S., Viloria-Petit, A., Okada, F., and Rak, J. Establishing a link between oncogenes and tumor angiogenesis. Mol. Med., 4: 286-295, 1998.
21. Rak, J., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R. S. Mutant ras oncogenes up-regulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res., 55: 4575-4580, 1995.
22. Larcher, F., Robles, A. I., Duran, H., Murillas, R., Quintanilla, M., Cano, A., Conti, C. J., and Jorcano, J. L. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res., 56: 5391-5396, 1996.
23. Jiang, B. H., Agani, F., Passaniti, A., and Semenza, G. L. V-SRC induces expression of hypoxia-induciblefactor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res., 57: 5328-5335, 1997.
24. Mukhopadhyay, D., Tsiokas, L., Zhou, X. M., Foster, D., Brugge, J. S., and Sukhatme, V. P. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature (Lond.), 375: 577-581, 1995.
25. Slack, J. L., and Bornstein, P. Transformation by v-src causes transient induction followed by repression of mouse thrombospondin-1. Cell Growth Differ., 5: 1373-1380, 1994.
26. Mettouchi, A., Gabon, F., Montreau, N., Vernier, P., Mercier, G., Blangy, D., Tricoire, H., Vigier, P., and Binetruy, B. SPARC and thrombospondin genes are repressed by the c-jun oncogene in rat embryo fibroblasts. EMBO J., 13: 5668-5678, 1994.
27. Bein, K., Ware, J. A., and Simons, M. Myb-dependent regulation of thrombospondin 2 expression. Role of mRNA stability. J. Biol. Chem., 273: 21423-21429, 1998.
28. Zabrenetzky, V., Harris, C. C., Steeg, P. S., and Roberts, D. D. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int. J. Cancer, 59: 191-195, 1994.
29. Arbiser, J. L., Moses, M. A., Fernandez, C. A., Ghiso, N., Cao, Y., Klauber, N., Frank, D., Brownlee, M., Flynn, E., Parangi, S., Byers, H. R., and Folkman, J. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc. Natl. Acad. Sci. USA, 94: 861-866, 1997.
30. Petit, A. M., Rak, J., Hung, M. C., Rockwell, P., Goldstein, N., Fendly, B., and Kerbel, R. S. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am. J. Pathol., 151: 1523-1530, 1997.
31. Perrotte, P., Matsumoto, T., Inoue, K., Kuniyasu, H., Eve, B. Y., Hicklin, D. J., Radinsky, R., and Dinney, C. P. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin. Cancer Res., 5: 257-265, 1999.
32. Tikhonenko, A. T., Black, D. J., and Linial, M. L. Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene. J. Biol. Chem., 271: 30741-30747, 1996.
33. Thompson, T. C., Southgate, J., Kitchener, G., and Land, H. Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell, 56: 917-930, 1989.
34. Land, H., Parada, L. F., and Weinberg, R. A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (Lond.), 304: 596-602, 1983.
35. Ribatti, D., Vacca, A., Nico, B., Fanelli, M., Roncali, L., and Dammacco, F. Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas: an immunohistochemical and ultrastructural study. Eur. J. Haematol., 56: 45-53, 1996.
36. Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., and Evan, G. I. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res., 23: 1686-1690, 1995.
37. Dhanaraj, S. N., Marcus, A. M., Korah, R. M., Iwata, K., and Small, M. B. Characterization of c-myc-transformed rat fibroblasts resistant to apoptosis induced ny growth factor deprivation. Exp. Cell Res., 224: 52-62, 1996.
38. Small, M. B., Hay, N., Schwab, M., and Bishop, J. M. Neoplastic transformation by the human gene N-myc. Mol. Cell. Biol., 7: 1638-1645, 1987.
39. Brown, J. M. The hypoxic cell: a target for selective cancer therapy. Cancer Res., 59: 5863-5870, 1999.
40. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. J. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
41. Shi, Y., Glynn, J. M., Guilbert, L. J., Cotter, T. G., Bissonette, R. P., and Green, D. R. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science (Washington DC), 257: 212-214, 1992.
42. Polverini, P. J., Bouck, N. P., and Rastinejad, F. Assay and purification of naturally occurring inhibitor of angiogenesis. Methods Enzymol., 198: 440-450, 1991.
43. Conn, G., Soderman, D. D., Schaeffer, M. T., Wile, M., Hatcher, V. B., and Thomas, K. A. Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc. Natl. Acad. Sci. USA, 87: 1323-1327, 1990.
44. Schwenk, F., Kuhn, R., Angrand, P. O., Rajewsky, K., and Stewart, A. F. Temporally and spatially regulated somatic mutagenesis in mice. Nucleic Acids Res., 26: 1427-1432, 1998.
45. Kibbey, M. C., Grant, D. S., and Kleinman, H. K. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. J. Natl. Cancer Inst., 84: 1633-1638, 1992.
46. Orkin, R. W., Gehron, P., McGoodwin, E. B., Martin, G. R., Valentine, T., and Swarm, R. A murine tumor producing a matrix of basement membrane. J. Exp. Med., 145: 204-220, 1977.
47. Danielson, K. G., Martinez-Hernandez, A., Hassell, J. R., and Iozzo, R. V. Establishment of a cell line from the EHS tumor: biosynthesis of basement membrane constituents and characterization of a hybrid proteoglycan containing heparan and chondroitin sulfate chains. Matrix, 12: 22-35, 1992.
48. Yurchenco, P. D., and Schittny, J. C. Molecular architecture of basement membranes. FASEB J., 4: 1577-1590, 1990.
49. Murphy, C. S., Langan-Fahey, S. M., McCague, R., and Jordan, V. C. Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro. Mol. Pharmacol., 38: 737-743, 1990.
50. Galaktionov, K., Chen, X., and Beach, D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature (Lond.), 382: 511-517, 1996.
51. Blackwood, E. M., and Eisenman, R. N. Max: a helix-loop-helix-zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science (Washington DC), 251: 1211-1217, 1991.
52. Amati, B., Dalton, S., Brooks, M. W., Littlewood, T. D., Evan, G. I., and Land, H. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature (Lond.), 359: 423-426, 1992.
53. Kretzner, L., Blackwood, E. M., and Eisenman, R. N. Myc and Max proteins possess distinct transcriptional activities. Nature (Lond.), 359: 426-429, 1992.
54. Grandori, C., Mac, J., Siebelt, F., Ayer, D. E., and Eisenman, R. N. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J., 15: 4344-4357, 1996.
55. Li, L., Nerlov, C., Prendergast, G. C., and Ziff, E. B. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J., 13: 4070-4079, 1994.
56. Marhin, W. W., Chen, S., Facchini, L. M., Fornace, A. J., and Penn, L. Z. Myc represses the growth arrest gene gadd45. Oncogene, 14: 2825-2834, 1997.
57. Facchini, L. M., and Penn, L. Z. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J., 12: 633-651, 1998.
58. Lawler, J., Sunday, M., Thibert, V., Duquette, M., George, E. L., Raybum, H., and Hynes, R. O. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J. Clin. Investig., 101: 982-992, 1998.
59. Pelengaris, S., Littlewood, T., Khan, M., Elia, G., and Evan, G. I. Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol. Cell, 3: 565-577, 1999.
60. Fotsis, T., Breit, S., Lutz, W., Rossler, J., Hatzi, E., Schwab, M., and Schweigerer, L. Down-regulation of endothelial cell growth inhibitors by enhanced MYCN oncogene expression in human neuroblastoma cells. Eur. J. Biochem., 263: 757-764, 1999.
61. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Identification of c-MYC as a target of the APC pathway. Science (Washington DC), 281: 1509-1512, 1998.
62. Rak, J., Filmus, J., and Kerbel, R. S. Reciprocal paracrine interactions between tumour cells and endothelial cells: the "angiogenesis progression" hypothesis. Eur. J. Cancer, 32A: 2438-2450, 1996.
63. Morgenstern, J. P., and Land, H. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res., 18: 1068. 1990.
64. Muthukkaruppan, V., and Auerbach, R. Angiogenesis in the mouse cornea. Science (Washington DC), 205: 1416-1418, 1979.
65. Tikhonenko, A. T., Hartman, A-R., and Linial, M. Overproduction of v-Myc in the nucleus and its excess over Max are not required for avian fibroblast transformation. Mol. Cell. Biol., 13: 3623-3631, 1993.